MyFinsight
Home
Blog
About
Net loss
attributable to common...
-$99,339K
(-714.12%↓ Y/Y)
Net loss and
comprehensive loss
-$96,267K
(-924.99%↓ Y/Y)
Cumulative dividend on
redeemable convertible...
$2,902K
(8.24%↑ Y/Y)
Accretion of redeemable
convertible preferred stock...
$170K
(31.78%↑ Y/Y)
Interest income, net
-$138K
(79.37%↑ Y/Y)
Advanced Wound Care
$36,146K
Surgical And Sports
Medicine
$6,659K
Net loss before
income taxes
-$50,880K
(-329.95%↓ Y/Y)
Income tax benefit
(expense)
$45,387K
(1958.60%↑ Y/Y)
Total other income,
net
$112K
(-84.91%↓ Y/Y)
Product
$42,805K
(-57.53%↓ Y/Y)
Grant
$950K
(320.35%↑ Y/Y)
Other income
(expense), net
-$26K
(-135.62%↓ Y/Y)
Loss from operations
-$50,992K
(-305.47%↓ Y/Y)
Total revenue
$43,755K
(-56.68%↓ Y/Y)
Total operating
expenses
$94,747K
(-16.58%↓ Y/Y)
Fair value
adjustment to assets held...
-$1,188K
Selling, general and
administrative
$53,965K
(-26.89%↓ Y/Y)
Cost of goods sold
$23,673K
(-14.32%↓ Y/Y)
Research and development
$18,297K
(76.02%↑ Y/Y)
Back
Back
Income Statement
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)
source: myfinsight.com